ecrin-mdr-crcClinical2022IPD Sharing (as of June 2023): NoColorectal CancerColorectal NeoplasmsColorectal CancerColorectal NeoplasmsInterventionalhttps://newmdr.ecrin.org/Study/2718019United States8Refractory metastatic colorectal cancerRelapsed metastatic colorectal cancerChimeric antigen receptors (CAR)ECRIN MDRRecruitingfalseGCC19CART for Patients With Metastatic Colorectal CancerStudy ICT-GCC19CART-US-001 (CARAPIA-1) is a Phase 1 study evaluating the safety, tolerability, clinical activity, pharmacokinetics and pharmacodynamics of GCC19CART in subjects with relapsed or refractory metastatic colorectal cancer.2022-08-152718019NCT05319314